Bulevirtide – March 2025

• Brand names:
  • Hepcludex®
• Pharmaceutical Company:
  • GILEAD SCIENCES PTY LTD
• Condition/Indication: Chronic hepatitis D
• Meeting Date: March 2025
• Public Summary Document (PSD) March 2025 July 2025 PBAC Meetings - (PDF 925KB)
• Public Summary Document (PSD) March 2025 July 2025 PBAC Meetings - (Word 218KB)

Related Public Summary Documents

• Bulevirtide – July 2025